WA-AVALARA
23.5.2023 15:01:36 CEST | Business Wire | Press release
Avalara, Inc., a leading provider of cloud-based tax compliance automation for businesses of all sizes, today unveiled Avalara E-Invoicing and Live Reporting, a new compliance API designed for multinational businesses to streamline their compliance with e-invoicing mandates around the world.
“While many businesses are investing in e-invoicing, they’re finding that the requirements are complex, vary by country, and are resource-intensive,” said Jayme Fishman, EVP and GM of Indirect Tax at Avalara. “Avalara has spent the last two decades addressing the complexity around indirect tax compliance for businesses and their trusted partners with our industry-leading compliance platform that makes tax less taxing. Now with Avalara E-Invoicing and Live Reporting, we’re extending that simplification to help clients and partners manage the new challenges and additional complexities of rapidly evolving e-invoicing mandates around the globe.”
E-invoicing mandates create new complexities for businesses
Today, more than 60 countries worldwide have announced or already have mandates for e-invoicing — a number that could more than double by 2030. Additionally, a growing number of countries have introduced other digital reporting requirements, including live reporting of invoice data and e-reporting of international sales and purchases.
While many businesses have implemented e-invoicing as a part of their digital transformation initiatives, the surge in government-driven and country-specific e-invoicing initiatives presents a unique challenge for businesses selling goods and services internationally. Governments view e-invoicing as an effective tool to enforce tax laws by increasing data visibility and further shoring up tax gaps.
As e-invoicing mandates grow in number, complying with them globally becomes more challenging and expensive. Local solutions are no longer sufficient for multinational businesses to meet compliance requirements efficiently. To keep up with the constantly evolving tax compliance environment, businesses must adopt a centralized approach to international compliance.
A single API to simplify and automate global e-invoicing requirements
Avalara E-Invoicing and Live Reporting helps businesses streamline international e-invoicing compliance, optimize payment and cash collection cycles, and save costs and resources. This flexible and scalable e-invoicing solution can be integrated into accounting, ecommerce, enterprise resource planning (ERP), and other invoicing systems via a single API that enables businesses to deploy e-invoicing simultaneously in multiple countries. The API is designed to adhere to evolving legislative requirements, helping businesses stay e-invoicing compliant globally. Avalara E-Invoicing and Live Reporting also allows partners to enhance their platforms by seamlessly addressing global e-invoicing requirements within their customer experience.
Avalara E-Invoicing and Live Reporting lets businesses quickly and securely:
- Set up global e-invoicing capabilities in their ERP, ecommerce, or accounting systems. Businesses can purchase Avalara E-Invoicing and Live Reporting from their ERP or accounting app store, set up their credentials, and configure the app based on their reporting needs.
- Access e-invoice exchange networks and government platforms. Businesses can connect to national (FACeB2B in Spain, for example) and international (e.g., Peppol) networks, as well as government e-invoicing platforms (KSeF in Poland, SDI in Italy, etc.).
- Support e-invoicing models by country or region. Businesses can connect to Avalara’s global API to fulfill e-invoicing mandates, including digital signatures, QR codes, digital archiving, and tax authority clearance and approvals.
- Monitor the status of e-invoices. Businesses can monitor the status of all their e-invoices from a single reporting console, providing real-time visibility on the life cycle of the e-invoice and any messages or errors returned by tax authorities.
- Set up archiving. Avalara E-Invoicing and Live Reporting can archive e-invoices to comply with data localization, security, and retention policies.
“The breadth and variation of e-invoicing requirements globally require a single solution that can automate and address e-invoicing in any country — regardless of rules or models,” said Kevin Permenter, Research Director at IDC. “Businesses stand to streamline their e-invoicing compliance by adopting a cloud-first solution that can easily integrate into the systems powering their invoices. Avalara’s e-invoicing API makes it possible for businesses to integrate e-invoicing into their finance functions and address global e-invoicing requirements from a single solution, saving them time, money, and resources.”
“E-invoicing is the clear direction of travel for tax authorities globally. The pace and quantum of new mandates is unprecedented and causing a huge headache for multinational businesses,” said Alex Baulf, Senior Director of E-Invoicing at Avalara. “Tax and finance functions now need to look at e-invoicing and live reporting of transactional data strategically — this is no longer a local compliance issue, it’s a critical global business issue. Avalara is offering a single way to help comply with a myriad of complex and changing e-invoicing requirements.”
Avalara has an extensive partner ecosystem comprised of more than 1,200 signed partner integrations, as well as a long history of providing tax compliance integrations with technology platforms across accounting, ecommerce, ERP, and more. Avalara will extend this strategy to provide out-of-the-box integrations that will make global adoption of e-invoicing truly a one-click experience for multinational companies. Earlier this year, Avalara announced the company’s expanded collection of e-invoicing certifications across Australia, Japan, New Zealand, and the European Union, as well as its involvement as a technical committee contributor for the Business Payments Coalition’s E-invoice Exchange Market Pilot in the U.S.
For additional information on Avalara E-Invoicing and Live Reporting, please click here and here. Partners interested in learning how they can help solve e-invoicing challenges for their customers, please visit our U.S. or Europe partner webpages.
About Avalara
Avalara helps businesses of all sizes get tax compliance right. In partnership with leading ERP, accounting, ecommerce, and other financial management system providers, Avalara delivers cloud-based compliance solutions for various transaction taxes, including sales and use, VAT, GST, excise, communications, lodging, and other indirect tax types. Headquartered in Seattle, Avalara has offices across the U.S. and around the world in Brazil, Europe, and India. More information at avalara.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005355/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
